These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36533178)

  • 21. Subtyping of early-onset Parkinson's disease using cluster analysis: A large cohort study.
    Zhou Z; Zhou X; Xiang Y; Zhao Y; Pan H; Wu J; Xu Q; Chen Y; Sun Q; Wu X; Zhu J; Wu X; Li J; Yan X; Guo J; Tang B; Lei L; Liu Z
    Front Aging Neurosci; 2022; 14():1040293. PubMed ID: 36437996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology.
    Gaertner Z; Azcorra M; Dombeck DA; Awatramani R
    Neurobiol Dis; 2022 Dec; 175():105925. PubMed ID: 36372290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era.
    Li D; Mastaglia FL; Fletcher S; Wilton SD
    Med Res Rev; 2020 Nov; 40(6):2650-2681. PubMed ID: 32767426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy of Parkinson's Disease Subtypes.
    Marras C; Chaudhuri KR; Titova N; Mestre TA
    Neurotherapeutics; 2020 Oct; 17(4):1366-1377. PubMed ID: 32749651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four-Year Longitudinal Study of Motor and Non-motor Symptoms in
    Deng X; Xiao B; Li HH; Ng E; Lo YL; Tan EK; Prakash KM
    Front Neurol; 2019; 10():1379. PubMed ID: 32010044
    [No Abstract]   [Full Text] [Related]  

  • 26. More Research Is Needed on Lifestyle Behaviors That Influence Progression of Parkinson's Disease.
    Nag N; Jelinek GA
    Front Neurol; 2019; 10():452. PubMed ID: 31114542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype-driven therapeutic developments in Parkinson's disease.
    Prasuhn J; Brüggemann N
    Mol Med; 2021 Apr; 27(1):42. PubMed ID: 33874883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
    PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease.
    Schneider SA; Alcalay RN
    J Neurol; 2020 Mar; 267(3):860-869. PubMed ID: 31974807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.
    Bandres-Ciga S; Diez-Fairen M; Kim JJ; Singleton AB
    Neurobiol Dis; 2020 Apr; 137():104782. PubMed ID: 31991247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data.
    Albrecht F; Poulakis K; Freidle M; Johansson H; Ekman U; Volpe G; Westman E; Pereira JB; Franzén E
    Parkinsonism Relat Disord; 2022 Sep; 102():19-29. PubMed ID: 35932584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.
    von Linstow CU; Gan-Or Z; Brundin P
    Transl Neurodegener; 2020 Oct; 9(1):39. PubMed ID: 33066808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling Parkinson's Disease Heterogeneity to Accelerate Precision Medicine.
    Olivares GH; Olguín P; Klein AD
    Trends Mol Med; 2019 Dec; 25(12):1052-1055. PubMed ID: 31676188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward precision medicine in Parkinson's disease.
    Bu LL; Yang K; Xiong WX; Liu FT; Anderson B; Wang Y; Wang J
    Ann Transl Med; 2016 Jan; 4(2):26. PubMed ID: 26889479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin.
    Senkevich K; Rudakou U; Gan-Or Z
    Neuropharmacology; 2022 Jan; 202():108822. PubMed ID: 34626666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities.
    Prasuhn J; Davis RL; Kumar KR
    Front Cell Dev Biol; 2020; 8():615461. PubMed ID: 33469539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of Parkinson's Disease: An Introduction.
    Titova N; Qamar MA; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():183-196. PubMed ID: 28554407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.